161 related articles for article (PubMed ID: 32148541)
1. Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology.
Xu W; Tang M; Wang J; Wang L
Evid Based Complement Alternat Med; 2020; 2020():4086864. PubMed ID: 32148541
[TBL] [Abstract][Full Text] [Related]
2. The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/β-catenin pathway.
Zhang Y; Zhou H; Ding C
Gynecol Endocrinol; 2023 Dec; 39(1):2181637. PubMed ID: 36822223
[No Abstract] [Full Text] [Related]
3. A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome.
Liu L; Du B; Zhang H; Guo X; Zhou Z; Xiu A; Liu C; Su S; Ai H
Chin Med; 2018; 13():46. PubMed ID: 30181771
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of
Ma JX; Ye M; Ma K; Zhou K; Zhang Y; Wang X; Tong H
Evid Based Complement Alternat Med; 2021; 2021():6651307. PubMed ID: 34457027
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract][Full Text] [Related]
6. Effects of Cangfu Daotan Decoction on obese polycystic ovary syndrome and its mechanism.
Yi W; Li X; Chen K; Zhu M; Cai X; Pan A
Steroids; 2021 Jan; 165():108740. PubMed ID: 33137356
[TBL] [Abstract][Full Text] [Related]
7. Analysis on the therapeutic effect of Cangfu Daotan Decoction combined with drospirenone and ethinylestradiol tablets (II) on patients with polycystic ovary syndrome.
Fu Y; Xie P; Yang Q; Chen P; Yu J
Prostaglandins Other Lipid Mediat; 2024 Feb; 170():106801. PubMed ID: 37984794
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
[TBL] [Abstract][Full Text] [Related]
9. Exploring the molecular targets and mechanism of
Yu H; Zhang L; Yin F; Zhan C; Chen J; Chu J
Ann Transl Med; 2023 Feb; 11(3):149. PubMed ID: 36846000
[TBL] [Abstract][Full Text] [Related]
10. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
Ma K; Gong LJ; Chen YX; Tian CD
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
[TBL] [Abstract][Full Text] [Related]
11. Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance
Liu S; Zhang Y; Yang F; Gu J; Zhang R; Kuang Y; Mai W; Zheng C; Yu Y; Lu R; Zeng L; Cao H; Long Y
Front Endocrinol (Lausanne); 2022; 13():975724. PubMed ID: 36440213
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology.
Zhang YY; Ma JX; Zhu YT; Wang YX; Chen WQ; Sun X; Zhang W; Wang CY; Ding CF
J Ovarian Res; 2022 Apr; 15(1):40. PubMed ID: 35379295
[TBL] [Abstract][Full Text] [Related]
13. Integrated Network Pharmacology and Clinical Study to Reveal the Effects and Mechanisms of Bushen Huoxue Huatan Decoction on Polycystic Ovary Syndrome.
Ding J; Shanshan M; Mengcheng C; Danying Z; Jin Y
Evid Based Complement Alternat Med; 2022; 2022():2635375. PubMed ID: 35600955
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Zhen Wu Decoction in the Treatment of Heart Failure Based on Network Pharmacology and Molecular Docking.
Ma CY; Ma YQ; Deng M
Evid Based Complement Alternat Med; 2022; 2022():4877920. PubMed ID: 35341142
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
Que DH; Chen WH; Jiang FP; Pan F; Yang K
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
Yu Y; Yang F; Liu H
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism and experimental verification of Dachengqi Decoction in treatment of sepsis based on network pharmacology].
Fu ZH; Zhao LL; Zhou L; Li XC; Zhang XC
Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5351-5361. PubMed ID: 34738439
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
[TBL] [Abstract][Full Text] [Related]
19. [Identification of potential targets and synergistic mechanism of Kushen Decoction for the treatment of cryptosporidiosis].
Zhan N; Liu XH; Tang FY; Zhang JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Oct; 33(5):483-495. PubMed ID: 34791846
[TBL] [Abstract][Full Text] [Related]
20. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
